Gu J, Tamura M, Pankov R, Danen E H, Takino T, Matsumoto K, Yamada K M
Craniofacial Developmental Biology and Regeneration Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland 20892-4370, USA.
J Cell Biol. 1999 Jul 26;146(2):389-403. doi: 10.1083/jcb.146.2.389.
Cell migration is modulated by regulatory molecules such as growth factors, oncogenes, and the tumor suppressor PTEN. We previously described inhibition of cell migration by PTEN and restoration of motility by focal adhesion kinase (FAK) and p130 Crk-associated substrate (p130(Cas)). We now report a novel pathway regulating random cell motility involving Shc and mitogen-activated protein (MAP) kinase, which is downmodulated by PTEN and additive to a FAK pathway regulating directional migration. Overexpression of Shc or constitutively activated MEK1 in PTEN- reconstituted U87-MG cells stimulated integrin- mediated MAP kinase activation and cell migration. Conversely, overexpression of dominant negative Shc inhibited cell migration; Akt appeared uninvolved. PTEN directly dephosphorylated Shc. The migration induced by FAK or p130(Cas) was directionally persistent and involved extensive organization of actin microfilaments and focal adhesions. In contrast, Shc or MEK1 induced a random type of motility associated with less actin cytoskeletal and focal adhesion organization. These results identify two distinct, additive pathways regulating cell migration that are downregulated by tumor suppressor PTEN: one involves Shc, a MAP kinase pathway, and random migration, whereas the other involves FAK, p130(Cas), more extensive actin cytoskeletal organization, focal contacts, and directionally persistent cell motility. Integration of these pathways provides an intracellular mechanism for regulating the speed and the directionality of cell migration.
细胞迁移受生长因子、癌基因和肿瘤抑制因子PTEN等调节分子的调控。我们之前描述过PTEN对细胞迁移的抑制作用,以及粘着斑激酶(FAK)和p130 Crk相关底物(p130(Cas))对迁移能力的恢复作用。我们现在报告一条涉及Shc和丝裂原活化蛋白(MAP)激酶的调节随机细胞迁移的新途径,该途径受PTEN下调,并且与调节定向迁移的FAK途径相加。在PTEN重构的U87-MG细胞中过表达Shc或组成型激活的MEK1可刺激整合素介导的MAP激酶激活和细胞迁移。相反,过表达显性负性Shc可抑制细胞迁移;Akt似乎未参与其中。PTEN直接使Shc去磷酸化。由FAK或p130(Cas)诱导的迁移具有方向持续性,涉及肌动蛋白微丝和粘着斑的广泛组织。相比之下,Shc或MEK1诱导一种随机类型的迁移,与较少的肌动蛋白细胞骨架和粘着斑组织相关。这些结果确定了两条由肿瘤抑制因子PTEN下调的调节细胞迁移的不同且相加的途径:一条涉及Shc、一条MAP激酶途径和随机迁移,而另一条涉及FAK、p130(Cas)、更广泛的肌动蛋白细胞骨架组织、粘着斑和方向持续性细胞迁移。这些途径的整合为调节细胞迁移的速度和方向性提供了一种细胞内机制。